Pharmacokinetic and pharmacodynamic studies of supaglutide in rats and monkeys

药代动力学 药效学 加药 药理学 生物利用度 皮下注射 医学 排泄 尿 内科学 内分泌学
作者
Yijing Liao,Anran Ma,Zhihong Wang,Yue Zhou,Lin Liu,Na Zhang,Li Zhang,Gérald J. Prud’homme,Qinghua Wang
出处
期刊:European Journal of Pharmaceutical Sciences [Elsevier BV]
卷期号:175: 106218-106218 被引量:1
标识
DOI:10.1016/j.ejps.2022.106218
摘要

We demonstrated recently that supaglutide, a novel GLP-1 mimetic generated by recombinant fusion protein techniques, exerted hypoglycemic effects in type 2 diabetes db/db mice and spontaneous diabetic monkeys. In this study, we investigated the pharmacokinetics and pharmacodynamics of supaglutide by single subcutaneous and intravenous injection(s) in rats and rhesus monkeys, as well as fourconsecutive subcutaneous injections in monkeys.We found the half-life (t1/2) of supaglutide was 39.7 h and 35.8 h at dosing 0.1 mg/kg upon subcutaneous or intravenous administration respectively, in rhesus monkeys. The plasma supaglutide peaked at 8-10 h, while the plasma drug exposure levels increased with the increase of dose, showing approximately a linear pharmacokinetic characteristic. The elimination kinetics (Ke) were found to be similar between subcutaneous (∼0.025 in rats and ∼0.018 in monkeys) and intravenous administration (0.021 in rats and 0.020 in monkeys), whereas the bioavailability was found to be 31.1% in rats and 63.9% in monkeys. In monkeys, a single dose injection of supaglutide markedly decreased the random blood glucose levels that reaching the maxima effects in 14-16 h, gradually recovered and returned to the baseline level approximately after 72 h. 125I-supaglutide was found mainly distributed in the serum and organs rich in blood supply. Urine was found to be the primary excretion route of supaglutide, following by feces, but mostly not in bile.Our results show that supaglutide possess linear pharmacokinetic characteristics associated with prolonged hypoglycemic effects inanimals,suggestinga potential weekly dosing therapeutic reagent for the treatment of type 2 diabetes and metabolic diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
5秒前
Milton_z完成签到 ,获得积分10
5秒前
雨落瑾年完成签到,获得积分10
8秒前
酷波er应助yiyimx采纳,获得10
8秒前
9秒前
9秒前
苦酷发布了新的文献求助10
10秒前
tzjz_zrz完成签到,获得积分10
10秒前
11秒前
隐形山芙发布了新的文献求助10
13秒前
王博士完成签到,获得积分10
16秒前
17秒前
苦酷完成签到,获得积分10
17秒前
南巷完成签到,获得积分10
17秒前
17秒前
Ryan完成签到,获得积分10
17秒前
科研通AI5应助lwl666采纳,获得10
18秒前
Chairs完成签到,获得积分0
19秒前
充电宝应助秋菲菲采纳,获得10
19秒前
顾暖完成签到,获得积分10
20秒前
大模型应助666采纳,获得10
21秒前
浅尝离白应助yif采纳,获得30
21秒前
JerryZ发布了新的文献求助10
22秒前
lwroche完成签到,获得积分10
25秒前
NIHAO213完成签到 ,获得积分10
25秒前
Danny完成签到,获得积分10
28秒前
朴实初夏完成签到 ,获得积分10
29秒前
29秒前
外向钢笔完成签到,获得积分10
30秒前
leotao完成签到,获得积分10
31秒前
遇见完成签到,获得积分10
32秒前
dajiejie完成签到 ,获得积分10
32秒前
琉璃发布了新的文献求助30
32秒前
32秒前
keyan123完成签到,获得积分10
33秒前
青橙晚完成签到,获得积分10
33秒前
35秒前
李小胖完成签到,获得积分10
37秒前
歪歪完成签到 ,获得积分10
37秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The First Nuclear Era: The Life and Times of a Technological Fixer 500
Unusual formation of 4-diazo-3-nitriminopyrazoles upon acid nitration of pyrazolo[3,4-d][1,2,3]triazoles 500
岡本唐貴自伝的回想画集 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3671625
求助须知:如何正确求助?哪些是违规求助? 3228325
关于积分的说明 9779625
捐赠科研通 2938636
什么是DOI,文献DOI怎么找? 1610180
邀请新用户注册赠送积分活动 760547
科研通“疑难数据库(出版商)”最低求助积分说明 736093